Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer
| Autor: | Wu, Y. *, Amonkar, M.M., Sherrill, B.H., O’Shaughnessy, J., Ellis, C., Baselga, J., Blackwell, K.L., Burstein, H.J. |
|---|---|
| Zdroj: | In Annals of Oncology December 2011 22(12):2582-2590 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|